骨肉瘤
转移
癌症研究
上皮-间质转换
车站3
癌变
MMP9公司
医学
体内
免疫学
下调和上调
生物
癌症
磷酸化
内科学
细胞生物学
生物技术
基因
生物化学
作者
Yu Han,Wei Guo,Tingting Ren,Yi Huang,Shidong Wang,Kuisheng Liu,Bingxin Zheng,Yang Kang,Hongliang Zhang,Xin Liang
出处
期刊:Cancer Letters
[Elsevier]
日期:2019-01-01
卷期号:440-441: 116-125
被引量:135
标识
DOI:10.1016/j.canlet.2018.10.011
摘要
Osteosarcoma (OS) is a common, malignant musculoskeletal tumor in young people. Neoadjuvant chemotherapy has improved the survival of osteosarcoma patients but with limited benefit due to metastasis. Tumor-associated macrophages (TAMs) are involved in various mechanisms of tumor biology, which include oncogenesis, drug resistance, and tumor immune escape, as well as tumor metastasis. In this study, we proved that TAMs possess the ability to promote OS cell migration and invasion by upregulating COX-2, MMP9, and phosphorylated STAT3 and to induce the epithelial-mesenchymal transition (EMT). This evidence has also been verified in a tumor-bearing animal model, and in OS patients. Furthermore, we observed the anti-metastasis effect of COX-2 inhibition by repressing COX-2 expression, EMT-activating transcription factors and the STAT3 pathway, both in vitro and in vivo. We propose that TAMs promote OS metastasis and invasion by activating the COX-2/STAT3 axis and EMT. These findings suggest that TAMs and COX-2 may be potential targets for future anti-metastasis therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI